Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer - Related Studies

Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer

This study is ongoing, but not recruiting participants.

Study NCT00058201. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pancreatic Cancer

2	Additional conditions recognized in this trial
		Pancreatic Neoplasms

3	More general conditions related to this trial
		Digestive System Diseases
		Digestive System Neoplasms
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Neoplasms
		Neoplasms by Site
		Pancreatic Diseases

4	Interventions listed in this trial
		fluorouracil
		gemcitabine hydrochloride
		leucovorin calcium
		observation

5	Additional drug interventions recognized in this trial
		Gemcitabine
		Leucovorin

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antiviral Agents
		Enzyme Inhibitors
		Growth Substances
		Immunologic Factors
		Immunosuppressive Agents
		Micronutrients
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses
		Vitamin B Complex
		Vitamins

7	Sponsors listed in this trial
		Royal Liverpool University Hospital
		National Cancer Institute of Canada
		Australasian Gastro-Intestinal Trials Group